Illumina Ventures to Launch Illumina® Ventures Labs
Illumina Ventures, a leading genomics and precision health venture firm, today announced plans to launch Illumina® Ventures Labs.
Now Available: Diagnostics Year in Review 2023. Click to Download Report.
Illumina Ventures, a leading genomics and precision health venture firm, today announced plans to launch Illumina® Ventures Labs.
Illumina Ventures, a genomics and precision health focused venture firm, today announced additions to its investment team. Abhijit “Ron” Mazumder, PhD, MBA, joins as a Partner and Lisa Alderson, MBA as an Entrepreneur in Residence.
Illumina Ventures announced the addition of four new members to its European team. Arnaud Autret, PhD, MSc, will be Principal and Head of European Operations, William Byrne, PhD, be an Associate – Europe, and Ronan Byrne and Ivan Coulter, PhD, BSc, will serve as Venture Advisors – Europe.
Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as an Entrepreneur in Residence.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.